Troy– Author –
-
Cell Grand Clinic in Japan Offers Non-Surgical Joint Pain Therapy: Culturing up to 200 Million Autologous Adipose-Derived Stem Cells over 7 Weeks for Direct Injection
Cell Grand Clinic Japan Overview Japan's Cell Grand Clinic announced its offering of a non-surgical joint pain therapy, involving the 7-week culture of autologous stem cells derived from a patient's fat, with up to 200 million cells inje... -
Xcellon Biologics Acquires NextCure’s 40,000-Square-Foot GMP Manufacturing Facility, Enhancing End-to-End CRDMO Capabilities for Next-Generation Bioconjugates and Complex Biologics
Outsourced Pharma USA Overview Xcellon Biologics has acquired NextCure's 40,000-square-foot GMP manufacturing facility, significantly bolstering its capabilities as an end-to-end CRDMO (Contract Research, Development, and Manufacturing O... -
Cellura Report: Human Pluripotent Stem Cell Culture Evolves, Building Next-Gen Manufacturing with Chemically Defined Xeno-Free Media, Advanced Biomaterials, Automated Production, and Intelligent Control
Cellura Unknown Overview Cellura reports a significant evolution in human pluripotent stem cell (hPSC) culture towards more reliable and reproducible cell manufacturing. This transformation is characterized by a shift to chemically defin... -
Cultivated Meat Faces Scientific, Sustainability, and Regulatory Hurdles: Microcarriers and Biomanufacturing Process Improvements are Critical
ResearchGate Unknown Overview A recent review highlights the major scientific, sustainability, and regulatory challenges confronting the cultivated meat industry. The study emphasizes the pivotal role of microcarriers as a key enabling t... -
Rapid Rise of iPSC-Based Therapies: Closed, Automated Cell Culture Systems Address Scalability and Cost Challenges for Allogeneic Treatments
Contract Pharma USA Overview Contract Pharma reported on the rapid advancements in iPSC-derived therapies, highlighting their potential as scalable solutions for allogeneic treatments and complex indications. The article details key chal... -
Scire Science Launches SBIO-420 Benchtop Bioreactor to Strengthen India’s Biomanufacturing Ecosystem with Precision and Enhanced Yields
Scire Science India Overview Scire Science unveiled the SBIO-420 Benchtop Magnetic Stirring Glass Bioreactor, aimed at strengthening India's biotechnology ecosystem. Designed for precision and ease of use, it supports advanced microbial ... -
CellFiber and Tidewave Bio Partner to Advance Next-Generation Solid Tumor Immunotherapy Manufacturing Scale-Up via 3D Cell Culture Platform
(Biotech News) Japan Overview CellFiber and Tidewave Bio announced a strategic collaboration to evaluate CellFiber's 3D cell culture platform for the scalable manufacturing of Tidewave's next-generation cell immunotherapy. This proof-of-... -
Virica Biotech Announces CAR-T Lentivirus Manufacturing Innovations and AAV Production Optimization with FUJIFILM
Virica Biotech Canada Overview Virica Biotech has announced innovative advancements in lentiviral vector manufacturing for CAR-T therapies, highlighted by a May 19, 2026, poster presentation featuring high productivity and smarter purifi... -
PackGene Biotech’s π-alpha 293 Platform Achieves 10x AAV Production Amplification, Up to 1e+17vg/Batch, Supporting Remedium Bio’s Gene Therapy Advancement
PackGene Biotech China Overview PackGene Biotech announced its innovative π-alpha 293 AAV high-yield platform, capable of amplifying adeno-associated virus (AAV) production up to 10-fold and achieving an impressive yield of up to 1e+17vg... -
Viral Vector Manufacturing: Global Leaders Scale Up Capacity with Advanced Platforms and Strategic Acquisitions
The Business Research Company International Overview The viral vector manufacturing market is experiencing rapid expansion as major players intensify efforts to scale production for gene therapies and vaccines. Recent strategic moves inc...
